VUZE Medical was incorporated in 2017 in Israel and is financed privately. Milestones so far include high accuracy and speed on an anatomical model (2018) and in cadaver surgeries (2019-2020), a first US Patent (2020), interoperability with X-Ray C-Arms from multiple vendors (2021), first European and Asian patents (2021), an FDA 510(k) submission (2021), successful first-in-human surgeries (late 2021) and FDA 510(k) clearance (early 2022).